EP: 5.RSV Vaccine Administration Timing and Errors EP: 6.Role of the Pharmacist in Vaccinating Against RSV EP: 7.What is RSV? EP: 8.Lasting Impacts of RSV EP: 9.Limiting Transmission of RSV EP: 10.Preparation of RSV Vaccines EP: 11.Role of Pharmacists in Improving Vaccine Uptake EP: ...
Intranasal administration of RSV antigen-expressing MCMV elicits robust tissue-resident effector and effector memory CD8+ T cells in the lungCytomegalovirus vectors are promising delivery vehicles for vaccine strategies that aim to elicit effector CD8+ T cells. To determine how the route of immunization...
At a meeting Thursday of the Advisory Committee on Immunization Practices, vaccine safety experts from the two agencies presented data that showed what appears to be an elevated rate of GBS, as the condition is called, among people who got the Pfizer vaccine, although there were ...
Respiratory syncytial virus (RSV) G glycoprotein has recently reemerged as a vaccine antigen due to its ability to elicit potent neutralizing antibodies and ameliorate disease in animal models. Here we designed three constructs to display the G central conserved domain (Gcc) focused on inducing broad...
Bovine respiratory syncytial virus, a major cause of respiratory disease in calves, is closely related to human RSV, a leading cause of respiratory disease in infants. Recently, promising human RSV-vaccine candidates have been engineered that stabilize the metastable fusion (F) glycoprotein in its ...
While it is unlikely that children with respiratory distress would be unma naged at presentation at the hospital, these analyses highlight the importance of reducing the time from first presentation for medical care to first study drug administration to better capture the value of RSV ...
Blue Lake Biotechnology, Inc. today announced preliminary data from the first two cohorts of a Phase 1/2a clinical trial studying BLB201, the company’s investigational vaccine against severe respiratory syncytial virus (RSV) disease.
A reduced alpha diversity of the upper re- spiratory tract has also been shown in a longitudinal co- hort study of symptomatic rhinovirus infections in infants (< 1 year) [31] and after administration of an intranasal live-attenuated influenza vaccine in adults [32]. Both stud- ies were ...
A reduced alpha diversity of the upper re- spiratory tract has also been shown in a longitudinal co- hort study of symptomatic rhinovirus infections in infants (< 1 year) [31] and after administration of an intranasal live-attenuated influenza vaccine in adults [32]. Both stud- ies were ...
Dramatic reduction and decrease of RSV titers in lung tissues and in the nasal tract, respectively, following intranasal virus challenge revealed biological relevance of the transcutaneous immunization in the context of RSV vaccine. These results suggest that the transcutaneous route may offer a ...